SLC25A11
Basic information
Region (hg38): 17:4937130-4940053
Previous symbols: [ "SLC20A4" ]
Links
Phenotypes
GenCC
Source:
- hereditary pheochromocytoma-paraganglioma (Supportive), mode of inheritance: AD
- paragangliomas 6 (Limited), mode of inheritance: Unknown
- paragangliomas 6 (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Pheochromocytoma/paraganglioma syndrome 6 | AD | Oncologic | The condition can involve increased risk of the development of ceratain types of neoplasms, and awareness may allow early diagnosis and management | Oncologic | 29431636 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC25A11 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 22 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 5 | |||||
Total | 0 | 0 | 24 | 7 | 1 |
Variants in SLC25A11
This is a list of pathogenic ClinVar variants found in the SLC25A11 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-4937761-G-A | Uncertain significance (Jun 19, 2024) | |||
17-4937769-G-A | Uncertain significance (Nov 19, 2024) | |||
17-4937791-A-C | not specified | Uncertain significance (Oct 07, 2024) | ||
17-4937795-G-A | Uncertain significance (Sep 12, 2024) | |||
17-4937829-T-C | Uncertain significance (Oct 02, 2024) | |||
17-4937837-C-T | Likely benign (Oct 02, 2024) | |||
17-4937854-G-A | Likely benign (May 29, 2024) | |||
17-4937858-G-T | not specified • Paragangliomas 6 | Uncertain significance (Jan 11, 2025) | ||
17-4937874-C-T | not specified | Uncertain significance (Nov 19, 2024) | ||
17-4937875-G-A | not specified | Uncertain significance (Nov 13, 2024) | ||
17-4938039-T-G | not specified | Uncertain significance (Nov 17, 2022) | ||
17-4938042-G-A | Uncertain significance (Dec 15, 2024) | |||
17-4938058-T-A | not specified | Uncertain significance (Jul 27, 2024) | ||
17-4938088-C-T | Benign (Jan 25, 2025) | |||
17-4938094-G-T | Likely benign (Jun 24, 2024) | |||
17-4938145-C-A | Benign (Nov 06, 2024) | |||
17-4938155-G-T | Uncertain significance (May 01, 2024) | |||
17-4938164-C-T | not specified | Uncertain significance (Sep 11, 2024) | ||
17-4938176-G-T | Paragangliomas 6 | Pathogenic (Oct 17, 2023) | ||
17-4938183-G-A | Paragangliomas 6 | Pathogenic (Oct 17, 2023) | ||
17-4938220-C-T | not specified | Conflicting classifications of pathogenicity (Jan 12, 2025) | ||
17-4938262-G-A | Uncertain significance (Jun 23, 2024) | |||
17-4938269-C-T | Likely benign (Jul 19, 2024) | |||
17-4938400-G-A | SLC25A11-related disorder | Likely benign (Aug 07, 2019) | ||
17-4938405-C-T | not specified | Uncertain significance (Jun 22, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC25A11 | protein_coding | protein_coding | ENST00000225665 | 8 | 3122 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.535 | 0.465 | 125716 | 0 | 7 | 125723 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.49 | 105 | 205 | 0.511 | 0.0000134 | 2008 |
Missense in Polyphen | 20 | 72.57 | 0.27559 | 608 | ||
Synonymous | -0.516 | 88 | 82.1 | 1.07 | 0.00000516 | 666 |
Loss of Function | 2.89 | 3 | 15.2 | 0.198 | 8.47e-7 | 159 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000905 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000468 | 0.0000462 |
European (Non-Finnish) | 0.0000354 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the transport of 2-oxoglutarate across the inner mitochondrial membrane in an electroneutral exchange for malate or other dicarboxylic acids, and plays an important role in several metabolic processes, including the malate-aspartate shuttle, the oxoglutarate/isocitrate shuttle, in gluconeogenesis from lactate, and in nitrogen metabolism (By similarity). Maintains mitochondrial fusion and fission events, and the organization and morphology of cristae (PubMed:21448454). Involved in the regulation of apoptosis (By similarity). {ECO:0000250|UniProtKB:P97700, ECO:0000250|UniProtKB:Q9CR62, ECO:0000269|PubMed:21448454}.;
- Pathway
- Transfer of Acetyl Groups into Mitochondria;Malate-Aspartate Shuttle;Gluconeogenesis;Glycogenosis, Type IA. Von gierke disease;Glycogenosis, Type IC;Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease;Triosephosphate isomerase;Fructose-1,6-diphosphatase deficiency;Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1);Glycogenosis, Type IB;Metabolism of carbohydrates;Metabolism;TCA cycle;Gluconeogenesis;Glucose metabolism
(Consensus)
Recessive Scores
- pRec
- 0.318
Intolerance Scores
- loftool
- 0.129
- rvis_EVS
- -0.34
- rvis_percentile_EVS
- 30.07
Haploinsufficiency Scores
- pHI
- 0.269
- hipred
- Y
- hipred_score
- 0.686
- ghis
- 0.616
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.973
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc25a11
- Phenotype
Gene ontology
- Biological process
- gluconeogenesis;alpha-ketoglutarate transport;transmembrane transport
- Cellular component
- nucleus;mitochondrion;mitochondrial inner membrane;integral component of plasma membrane
- Molecular function
- RNA binding;oxoglutarate:malate antiporter activity